Understanding Viagra's main function and active ingredient, Sildenafil

Viagra, also known by its generic name sildenafil, is predominantly used to treat erectile dysfunction (ED). It does not act as a blood thinner but functions as a PDE5 inhibitor. A common misconception is that Viagra thins the blood. However, it is important to clarify that its primary function revolves around the PDE5 enzyme.

Explanation of PDE5 enzyme and its inhibition by Viagra

The PDE5 enzyme is key to the way Viagra works. When this enzyme is inhibited by Viagra, it allows for increased blood flow, specifically to the penis. This process makes it easier for men to gain and maintain an erection, thereby counteracting the effects of ED.

Effect of Viagra on blood flow and erections

While Viagra does influence blood flow, it acts locally and specifically targets PDE5 activity, primarily increasing blood flow to the penis.The notion that Viagra acts as a blood thinner may be due to its impact on blood flow.However, these two effects should not be conflated.

Increased blood flow doesn't necessarily equate to blood thinning.

Examination of Viagra's influence on blood pressure

Viagra can cause a decrease in blood pressure, particularly 1 to 2 hours after ingestion. However, this effect is separate from any blood thinning actions. Viagra and blood pressure medications can both independently lower blood pressure. It should be noted that when taken in combination, these medications can potentiate each other's hypotensive effects.

Addressing the question: Is Viagra a blood thinner?

In response to the query "Is Viagra a blood thinner?", the answer is no. Viagra does not have blood thinning effects nor does it provoke the occurrence of blood clots or destroy existing ones. There have been some cases of bleeding events in people taking sildenafil. However, it has not been definitively established if this is directly related to sildenafil use.

Scientific evidence on Viagra and blood thinning

At present, there's no scientific evidence to suggest that sildenafil is an effective anticoagulant, or blood thinner. This belief likely stems from Viagra's early history as a cardiovascular medication and its role in regulating blood flow. Yet, it is crucial to remember that managing blood flow does not equate to blood thinning.

Understanding the difference between blood thinners and anticoagulants in relation to Viagra

Viagra widens blood vessels, improving oxygen supply to the body by facilitating increased blood flow through the heart. However, this action doesn't involve thinning the blood or exhibiting anticoagulant properties. Most men can safely take anticoagulants like warfarin (Coumadin) and enoxaparin (Lovenox) with ED medications like Viagra. Yet, Viagra itself doesn't function as an anticoagulant or blood thinner.

Summarizing the effects of Viagra on the circulatory system

While Viagra does have a series of effects on the circulatory system, from widening blood vessels to decreasing blood pressure, it is not a blood thinner. Its main action is to inhibit the PDE5 enzyme, facilitating erectile function. However, like any medication, Viagra can cause side effects, including sudden vision or hearing loss, heart attack, stroke, irregular heartbeats, and even death. These side effects are, however, rare and should be discussed with a healthcare provider before starting treatment with Viagra.

16 AUGUST 2011: OUTCOME OF ARHA’S EXTRAORDINARY GENERAL MEETING

An Extraordinary General Meeting of the members of the Australian Reproductive Health Alliance (ARHA) was held on Monday August 15th 2011.

The meeting was convened to consider the resolution that, in view of the continuing financial insecurity facing the Alliance and the decision of the Parliamentary Group on Population and Development to transfer its Secretariat to another organisation, the Australian Reproductive Health Alliance cease on September 30th 2011.

The motion was passed unanimously and ARHA will cease to exist in any form after that date.

The decision to close an organisation which has achieved so much over the past 15 years was taken in sadness. The Management Committee of ARHA would like to thank all those members and supporters who have sustained us in so many ways over that time.

For more information please do not hesitate to contact Susan Stratigos, ARHA President, on +61 (0)2 6278 6948 or 0402 957 259.

 
 

Member of ACFID & Signatory to the ACFID Code of Conduct.
NGO Special Consultative Status with the Economic and Social Council of the United Nations